LOVELAND, Colo., Nov. 3, 2016
LOVELAND, Colo., Nov. 3, 2016 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 17, 2016 at 8:30 a.m. ET.
The conference will be held at the Westin New York Grand Central, New York, NY on November 17, 2016.
A live webcast of the group presentation will be available at http://wsw.com/webcast/canaccord24/hska. This webcast will be archived for 90 following the live presentation. Management will be available during the day on November 17 for one-on-one meetings. To schedule a one-on-one meeting, please contact Hayden IR at email@example.com.
Heska Corporation (NASDAQ:HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heska-to-present-at-canaccord-genuity-medical-technologies--diagnostics-forum-on-november-17-300356517.html
SOURCE Heska CorporationPR Newswire
Last updated on: 03/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.